Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Cavia porcellus | 3-beta-hydroxysteroid-delta(8),delta(7)-isomerase | Starlite/ChEMBL | References |
Rattus norvegicus | Dopamine D2 receptor | Starlite/ChEMBL | References |
Rattus norvegicus | Serotonin 1a (5-HT1a) receptor | Starlite/ChEMBL | References |
Cavia porcellus | Sigma-1 receptor | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | serotonin receptor | 0.0317 | 0.6953 | 1 |
Trypanosoma brucei | C-8 sterol isomerase, putative | 0.0445 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.002 | 0.002 |
Echinococcus granulosus | biogenic amine 5HT receptor | 0.0317 | 0.6953 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0445 | 1 | 1 |
Plasmodium falciparum | DNA gyrase subunit B | 0.0041 | 0.0365 | 0.1539 |
Trypanosoma cruzi | Emopamil binding protein, putative | 0.0166 | 0.3347 | 0.3347 |
Schistosoma mansoni | biogenic amine (5HT) receptor | 0.0317 | 0.6953 | 0.7333 |
Trypanosoma cruzi | 3-Beta-hydroxysteroid-delta(8), delta(7)-isomerase, putative | 0.0166 | 0.3347 | 0.3347 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.002 | 0.002 |
Trypanosoma cruzi | mitochondrial DNA topoisomerase II, putative | 0.0099 | 0.1734 | 0.1734 |
Brugia malayi | Probable DNA topoisomerase II | 0.0125 | 0.2374 | 0.2374 |
Onchocerca volvulus | 0.0166 | 0.3347 | 1 | |
Trypanosoma cruzi | DNA topoisomerase II, putative | 0.0113 | 0.2073 | 0.2073 |
Chlamydia trachomatis | DNA gyrase subunit B | 0.0068 | 0.1005 | 1 |
Schistosoma mansoni | amine GPCR | 0.0423 | 0.9482 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0055 | 0.0704 | 0.0704 |
Leishmania major | DNA topoisomerase ii | 0.0113 | 0.2073 | 0.2073 |
Leishmania major | hypothetical protein, conserved | 0.0166 | 0.3347 | 0.3347 |
Loa Loa (eye worm) | hypothetical protein | 0.0055 | 0.0704 | 0.0704 |
Loa Loa (eye worm) | hypothetical protein | 0.0317 | 0.6953 | 0.6953 |
Schistosoma mansoni | DNA topoisomerase II | 0.0125 | 0.2374 | 0.2504 |
Brugia malayi | DNA gyrase/topoisomerase IV, A subunit family protein | 0.0125 | 0.2374 | 0.2374 |
Trypanosoma brucei | DNA topoisomerase II alpha, putative | 0.0113 | 0.2073 | 0.2073 |
Trypanosoma cruzi | C-8 sterol isomerase, putative | 0.0445 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.002 | 0.002 |
Brugia malayi | Cytochrome P450 family protein | 0.0027 | 0.0015 | 0.0015 |
Loa Loa (eye worm) | hypothetical protein | 0.0084 | 0.1389 | 0.1389 |
Plasmodium vivax | DNA topoisomerase II, putative | 0.0125 | 0.2374 | 1 |
Trypanosoma cruzi | mitochondrial DNA topoisomerase II, putative | 0.0099 | 0.1734 | 0.1734 |
Echinococcus multilocularis | DNA topoisomerase 2 alpha | 0.0125 | 0.2374 | 0.3415 |
Entamoeba histolytica | DNA topoisomerase II, putative | 0.0125 | 0.2374 | 1 |
Trypanosoma brucei | DNA topoisomerase ii | 0.0099 | 0.1734 | 0.1734 |
Leishmania major | C-8 sterol isomerase-like protein | 0.0445 | 1 | 1 |
Echinococcus granulosus | DNA topoisomerase 2 alpha | 0.0125 | 0.2374 | 0.3415 |
Treponema pallidum | DNA gyrase, subunit B (gyrB) | 0.0041 | 0.0365 | 0.5 |
Trypanosoma brucei | DNA topoisomerase II beta, putative | 0.0113 | 0.2073 | 0.2073 |
Leishmania major | mitochondrial DNA topoisomerase II | 0.0099 | 0.1734 | 0.1734 |
Trypanosoma brucei | Emopamil binding protein, putative | 0.0166 | 0.3347 | 0.3347 |
Mycobacterium ulcerans | DNA gyrase subunit B | 0.0041 | 0.0365 | 0.5 |
Brugia malayi | DNA topoisomerase II, alpha isozyme | 0.0125 | 0.2374 | 0.2374 |
Toxoplasma gondii | DNA topoisomerase 2, putative | 0.0125 | 0.2374 | 1 |
Echinococcus multilocularis | serotonin receptor | 0.0317 | 0.6953 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0084 | 0.1389 | 0.1389 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0027 | 0.0015 | 0.0015 |
Leishmania major | 3-Beta-hydroxysteroid-delta(8), delta(7)-isomerase, putative | 0.0166 | 0.3347 | 0.3347 |
Loa Loa (eye worm) | TOPoisomerase family member | 0.0125 | 0.2374 | 0.2374 |
Loa Loa (eye worm) | hypothetical protein | 0.0317 | 0.6953 | 0.6953 |
Plasmodium falciparum | DNA topoisomerase 2 | 0.0125 | 0.2374 | 1 |
Toxoplasma gondii | ATPase/histidine kinase/DNA gyrase B/HSP90 domain-containing protein | 0.0041 | 0.0365 | 0.1539 |
Trypanosoma cruzi | Emopamil binding protein, putative | 0.0166 | 0.3347 | 0.3347 |
Plasmodium vivax | DNA gyrase subunit B, putative | 0.0041 | 0.0365 | 0.1539 |
Trypanosoma cruzi | 3-Beta-hydroxysteroid-delta(8), delta(7)-isomerase, putative | 0.0166 | 0.3347 | 0.3347 |
Trichomonas vaginalis | DNA topoisomerase II, putative | 0.0125 | 0.2374 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0227 | 0.4808 | 0.4808 |
Giardia lamblia | DNA topoisomerase II | 0.012 | 0.2242 | 1 |
Wolbachia endosymbiont of Brugia malayi | DNA gyrase, topoisomerase II, B subunit, GyrB | 0.0041 | 0.0365 | 0.5 |
Trypanosoma cruzi | DNA topoisomerase II, putative | 0.0113 | 0.2073 | 0.2073 |
Mycobacterium tuberculosis | DNA gyrase (subunit B) GyrB (DNA topoisomerase (ATP-hydrolysing)) (DNA topoisomerase II) (type II DNA topoisomerase) | 0.0041 | 0.0365 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | < 10 % | Cytotoxicity against human PC3 cells assessed as LDH release at 100 uM after 24 hrs relative to untreated control | ChEMBL. | 19053780 |
Ki (binding) | = 45.4 nM | Displacement of [3H](-)-(S)-emopamil from EBP in guinea pig liver membrane | ChEMBL. | 19053780 |
Ki (binding) | = 178 nM | Displacement of [3H](+)-pentazocine from sigma 1 receptor in guinea pig brain membrane without cerebellum | ChEMBL. | 19053780 |
Ki (binding) | = 815 nM | Displacement of [3H]8OH-DPAT from 5HT1A receptor in rat hippocampal membrane | ChEMBL. | 19053780 |
Ki (binding) | > 850 nM | Displacement of [3H]spiroperidol from dopamine D2 receptor in rat striatal membrane | ChEMBL. | 19053780 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.